Skip to main content
. 2020 Mar 30;34(3):255–263. doi: 10.1007/s40259-020-00411-4

Fig. 1.

Fig. 1

Algorithm for assessing FN risk and the need for primary prophylactic G-CSF. Adapted from guidelines by the European Organisation for Research and Treatment of Cancer [1], the European Society of Medical Oncology [5] and the National Comprehensive Cancer Network [16]. FN febrile neutropenia, G-CSF granulocyte-colony stimulating factor